About Progenicare
Progenicare is a Healthcare company based in Austin (United States) founded in 2008, and was acquired by ISTO Biologics in June 2017. Cell and gene therapy products and orthopedic services are provided. Its focus areas include Biopharma Outsourcing, Diversified and Cell & Gene Therapy. Its competitors include Blue Rock Therapeutics, Impel Pharmaceuticals and Ascend; 3 of its 3 listed competitors have raised funding.
Company details
Progenicare was established in 2008 and is based in Austin, United States. Operations are centered in the biotechnology and healthcare sectors, where cell and gene therapy clinical products are developed and supplied. Orthopedic solution services are also delivered to address therapeutic and clinical requirements. The focus remains on supporting advancements in regenerative medicine through these specialized offerings.
- Headquarters Austin, United States
- Stage Acquired
- SectorsHealthcare
- Website progenicare.com
- Social X Facebook
- Acquired by ISTO Biologics (Jun 2017)
- InvestorsISTO Biologics
& 1 more
- Acquired by
Investors in Progenicare
Progenicare has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ISTO Biologics and Sheridan Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sheridan Capital Partners is focused on healthcare private equity investments. | sheridancp.com | Chicago, United States | ||
Developer of treatments for cartilage and bone problems | 1997 | istobiologics.com | St. Louis, United States |
Investor details for Progenicare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Progenicare
3 dated milestones of Progenicare across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Progenicare is founded.
- Exit Acquired by Sheridan.
- Exit Acquired by ISTO Biologics.
Competitors of Progenicare
Progenicare has 3 listed competitors in our database, 3 of them funded. They include Blue Rock Therapeutics, Impel Pharmaceuticals and Ascend.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bluerocktx.com | 2016 | Boston, United States | $225M | 138 | Stem cell therapies are developed for cardiovascular and neurological diseases. | |
| impelpharma.com | 2008 | Seattle, United States | $67.5M | Transformative therapies are developed and commercialized through specialized services. | ||
| useascend.com | 2021 | Palo Alto, United States | $35.5M | 39 | Online insurance payments and premium financing are enabled for businesses. |
Detailed competitors of Progenicare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Progenicare (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Progenicare
Complete news archive for Progenicare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Progenicare
Progenicare was founded in 2008.
Progenicare is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Progenicare was established in 2008 and is based in Austin, United States. Operations are centered in the biotechnology and healthcare sectors, where cell and gene therapy clinical products are developed and supplied. Orthopedic solution services are also delivered to address therapeutic and clinical requirements. The focus remains on supporting advancements in regenerative medicine through these specialized offerings.
Progenicare's top competitors include Blue Rock Therapeutics, Ascend and Impel Pharmaceuticals.
Progenicare has 2 investors. Key investors include ISTO Biologics, and Sheridan Capital Partners.
Yes. Progenicare was acquired by ISTO Biologics in June 2017.